Gujarat Themis Biosyn gets nod to raise Rs 585 crore via NCDs

Gujarat Themis Biosyn has received approval for the issuance of Non-Convertible Debentures (NCDs) aggregating upto Rs 585 crore on private placement basis. The Board of Directors of the Company at its meeting held on September 10, 2026, has inter-alia considered and approved the same. 

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company.